| HOME >> BIOLOGY >> TECHNOLOGY |
Essilor also completed four small acquisitions in Australia, representing an aggregate EUR3.6 million in full-year revenue.
Share buybacks
During the quarter, Essilor purchased 220,418 of its own shares on the open market for a total of EUR6.3 million, as part of the program set up in July 2008 to offset dilution from the conversion of the OCEANE bonds.
Net debt
Due to the normal seasonal fluctuations in business, as well as acquisitions, share buybacks and capital expenditure, net debt increased by EUR50 million during the first quarter, to nearly EUR162 million at March 31, 2009.
-------------------------
A conference call in French will be held today at 9:00 a.m. CET.
The number to dial is: +33(0)1-70-99-42-78
The conference will be available for later listening at:
http://hosting.3sens.com/Essilor/20090423-E5AB9FB0/fr/
A conference call in English will follow at 10:00 a.m. CET.
The number to dial is: +44(0)20-78-06-19-66
The conference will be available for later listening at:
http://hosting.3sens.com/Essilor/20090423-E5AB9FB0/en/
Investor calendar:
May 15, 2008, 10:30 a.m.: Annual Shareholders' Meeting
July 17, 2009: First-half revenue announced
-----------------------
Essilor International is the world leader in ophthalmic optical products,
offering a wide range of lenses under the flagship Varilux(r), Crizal(r),
Essilor(r) and Definity(r) brands to correct myopia, hyperopia, presbyopia
and astigmatism. Essilor operates worldwide through 15 production sites, 293
lens f
'/>"/>
| SOURCE Essilor Copyright©2009 PR Newswire. All rights reserved |